Corrigendum

    TLDR The 7.1% withdrawal rate was in the oral finasteride group, not the topical one.
    In the article by B.M. Piraccini et al., there was an error in the "Safety assessment" subsection. The incorrect sentence stated that withdrawal rates due to treatment-related TEAEs were 2.8% and 2.2% in the topical finasteride and placebo groups, respectively, and 7.1% in the topical finasteride group. The corrected sentence clarifies that the 7.1% withdrawal rate was actually in the oral finasteride group.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    4 / 4 results